Islamabad [Pakistan], April 26 (ANI): Rawalpindi Drug Court has awarded imprisonment and heavy fines to the CEO and other employees of a pharmaceutical company, GlaxoSmithKline (GSK), over a case involving the distribution of substandard medicine, Dawn reported. The judgement, delivered after a trial in the Rawalpindi Drug Court found the accused guilty of negligence. Despite GSK’s reputation as a reputable company, the court ruled that it failed to address concerns regarding the substandard drug. The CEO faces imprisonment until the rising of the court and a substantial fine, with potential a…